Yahoo India Web Search

Search results

    • iOnctura expands PI3K inhibitor programme to NSCLC

      iOnctura expands PI3K inhibitor programme to NSCLC

      Pharmaceutical Technology· 24 hours ago

      Roginolisib is an allosteric modulator of phosphoinositide 3-kinase-δ (PI3Kδ), which iOnctura says is “widely recognised as a 'master switch' of cancer.”...